Advanced search
Publication Cover
Acta Cardiologica Volume 71, 2016 - Issue 6
Submit an article Journal homepage
10
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Total serum bilirubin is an independent risk factor for coronary artery disease in men compared to women

Anke NguyenSt Vincent’s Hospital Melbourne, Cardiology Department, Australia.
, MBBS,
Heath AdamsSt Vincent’s Hospital Melbourne, Cardiology Department, Australia.Correspondence[email protected]
, MBBS,
Julian GinUniversity of Melbourne, Australia.
, MBBS,
Natalie YapSt Vincent’s Hospital Melbourne, Cardiology Department, Australia.
, MBBS,
Amy Wilson-O’brienUniversity of Melbourne, Australia.
, PhD,
John GarlickUniversity of Melbourne, Australia.
, BSci &
Andrew M. WilsonSt Vincent’s Hospital Melbourne, Cardiology Department, Australia.;University of Melbourne, Australia.
, MBBS, PhD show all
Pages 685-689 | Received 12 Dec 2015, Accepted 04 Jan 2016, Published online: 23 May 2017

References

  • Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low-density lipoprotein better than Trolox. Life Sci 1994; 54: P477–81.
  • Kundur AR, Bulmer AC, Singh I. Unconjugated bilirubin inhibits collagen induced platelet activation. Platelets 2014; 25:45–50.
  • Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40: 18–23.
  • Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008; 121:781–8.
  • Lin LY, Kuo HK, Hwang JJ, Lai LP, Chiang FT, Tseng CD, Lin JL. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2009; 203: 563–8.
  • Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 166–72.
  • Djoussé L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001; 87: 1196–200; A4.7.
  • Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043–6.
  • Stocker R, Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 2006; 114: 2178–89.
  • Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004; 37: 1097–104.
  • Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest1999; 103: 129–35.
  • Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, NovotnY L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002; 160:449–56.
  • Kundur AR, Singh I, Bulmer AC. Bilirubin platelet activation and heart disease: A missing link to cardiovascular protection in Gilbert’s syndrome? Atherosclerosis 2015; 239: 73–84.
  • Kang SJ, Kim D, Park HE, Chung GE, Choi SH, Choi SY, Lee W, Kim JS, Cho SH. Elevated serum bilirubin levels are inversely associated with coronary atherosclerosis. Atherosclerosis 2013; 230: 242–8.
  • Zhang ZY, Bian LQ Kim SJ, Zhou CC, Choi YH. Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol 2012; 35: 301–6.
  • Horsfall U, Nazareth I, Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 2012; 126:2556–64.
  • Song Y, Koo BK, Cho NH, Moon MK. Effect of low serum total bilirubin levels 0.32 mg/di) on risk of coronary artery disease in patients with metabolic syndrome. Am J Cardiol 2014; 114: 1695–700.
  • Sahin O, Akpek M, Elcik D, Karadavut 5, Simsek V. Tulmac M, Orscelik O, Calapkorur B, Ergin A, Kaya MG. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEM. Angio/ogy 2013; 64: 200–4.
  • CelikT, Kaya MG, Akpek M, Yarlioglues M, Sarli B, Topsakal R, Gibson CM. Does serum bilirubin levels on admission predict TIMI flow grade and in-hospital MACE in patients with STEN undergoing primary PCI. Angiology 2014; 65: 198–204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.